Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Aurora Cannabis (ACB) Stock Price & Analysis

ACB Stock Chart & Stats

CA$5.95CA$0.29(5.12%)
At close: 11:30 AM EST
C$4C$5C$64 Aug17 Aug31 Aug14 Sep28 Sep13 Oct26 Oct
Day’s Range
CAD 5.57 - CAD 5.71
52-Week Range
CAD 3.59 - CAD 8.75
Previous Close
CAD 5.74
Volume
N/A
Average Volume (3M)
304.55K
Market Cap
CAD 372.12M
Enterprise Value
CAD 117.20M
Total Cash (Recent Filing)
CAD 149.12M
Total Debt (Recent Filing)
CAD 22.68M
Price to Earnings (P/E)
―
Beta
1.53
Next Earnings
Nov 12, 2026 (Est.)
EPS Estimate
-0.07
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

International Medical Growth

Strong international medical growth and a rising share of revenue generated outside Canada indicate expanding access to regulated markets. This geographic diversification can reduce dependence on Canadian demand while supporting longer-term scale, market share, and revenue resilience.

Margin And Production Advantages

A 58% adjusted gross margin, combined with genetics that may lift yields by up to 40% without a proportional cost increase, supports durable operating leverage. These advantages can strengthen competitiveness and help sustain margins as international volumes expand.

Debt-Free Balance Sheet

Nearly $150 million of liquidity and no debt provide meaningful financial flexibility for capacity expansion, acquisitions, and market development. The absence of debt also limits refinancing pressure, giving Aurora greater ability to absorb volatility while pursuing its growth strategy.

Bears Say

Declining Revenue And Persistent Losses

The revenue decline and continuing operating and net losses show that Aurora has not yet established durable earnings power. Until growth and profitability stabilize together, the company may have less internal capacity to fund expansion and greater exposure to execution setbacks.

Weak And Deteriorating Cash Generation

Negative operating and free cash flow indicate that the business is not currently self-funding, despite its cash reserves. If the burn persists, liquidity could be consumed by operations, reducing flexibility for investment and increasing the importance of a successful turnaround.

Canadian Reimbursement And Consumer Exit Headwinds

The reimbursement reduction directly pressures Canadian medical revenue and adjusted gross profit, while the consumer-business exit reduces revenue diversification. Together, these changes can weigh on reported growth and make Aurora more dependent on international execution.

Aurora Cannabis News

ACB FAQ

What was Aurora Cannabis’s price range in the past 12 months?
Aurora Cannabis lowest stock price was C$3.59 and its highest was C$8.75 in the past 12 months.
What is Aurora Cannabis’s market cap?
Aurora Cannabis’s market cap is C$372.12M.
When is Aurora Cannabis’s upcoming earnings report date?
Aurora Cannabis’s next earnings report is estimated for Nov 12, 2026 (not yet confirmed), which is in 9 days.
How were Aurora Cannabis’s earnings last quarter?
Aurora Cannabis released its earnings results on Aug 05, 2026. The company reported -C$0.07 earnings per share for the quarter, beating the consensus estimate of -C$0.183 by C$0.113.
Is Aurora Cannabis overvalued?
According to Wall Street analysts Aurora Cannabis’s price is currently Undervalued.
Does Aurora Cannabis pay dividends?
Aurora Cannabis does not currently pay dividends.
What is Aurora Cannabis’s EPS estimate?
Aurora Cannabis’s EPS estimate is -0.07.
How many shares outstanding does Aurora Cannabis have?
Aurora Cannabis has 65,744,810 shares outstanding.
What happened to Aurora Cannabis’s price movement after its last earnings report?
Aurora Cannabis reported an EPS of -C$0.07 in its last earnings report, beating expectations of -C$0.183. Following the earnings report the stock price went up 3.836%.
Which hedge fund is a major shareholder of Aurora Cannabis?
Currently, no hedge funds are holding shares in TSE:ACB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology